相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosis
Esraa M. Labib et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis
Heena Sareen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
An introduction to spatial transcriptomics for biomedical research
Cameron G. Williams et al.
GENOME MEDICINE (2022)
MicroRNAs as potential diagnostic markers of glial brain tumors
Albert Sufianov et al.
NON-CODING RNA RESEARCH (2022)
The histological representativeness of glioblastoma tissue samples
Vilde Elisabeth Mikkelsen et al.
ACTA NEUROCHIRURGICA (2021)
Estimating Local Cellular Density in Glioma Using MR Imaging Data
E. D. H. Gates et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2021)
MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation
Christoph Sippl et al.
NEUROSURGERY (2019)
miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme
Christoph Sippl et al.
ACTA NEUROCHIRURGICA (2019)
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
Anna Wenger et al.
NEURO-ONCOLOGY (2019)
MiR-21: A key player in glioblastoma pathogenesis
Mohammad Sadegh Masoudi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Upregulation of miR-125b, miR-181d, and miR-221 Predicts Poor Prognosis in MGMT Promoter-Unmethylated Glioblastoma Patients
Yen-Ying Chen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014
Haley Gittleman et al.
NEURO-ONCOLOGY (2018)
The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence
Shariq S. Khwaja et al.
Oncotarget (2018)
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer et al.
NATURE MEDICINE (2018)
BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity
Nozomi Nakajima et al.
BRAIN PATHOLOGY (2018)
MicroRNA in Glioblastoma: An Overview
Barbara Banelli et al.
INTERNATIONAL JOURNAL OF GENOMICS (2017)
Modulation of miR-21 signaling by MPS1 in human glioblastoma
Uday B. Maachani et al.
ONCOTARGET (2016)
Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
Srinivasulu Yerukala Sathipati et al.
BMC GENOMICS (2016)
SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
Chen Xiuju et al.
OPEN MEDICINE (2016)
Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma
Nicole R. Parker et al.
SCIENTIFIC REPORTS (2016)
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs
Jordan Anaya
PEERJ COMPUTER SCIENCE (2016)
MicroRNA as potential biomarkers in Glioblastoma
Zammam Areeb et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated
Pin Guo et al.
EXPERIMENTAL CELL RESEARCH (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
p16(INK4a) and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis
Didier Philipot et al.
ARTHRITIS RESEARCH & THERAPY (2014)
MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a
Simona Giglio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway
Ya-Fei Zhang et al.
MOLECULAR BIOLOGY REPORTS (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
Annette Bentsen Havik et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
Wei Zhang et al.
NEURO-ONCOLOGY (2012)
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
Radek Lakomy et al.
CANCER SCIENCE (2011)
Determination of the methylation status of MGMT in different regions within glioblastoma multiforme
Mark G. Hamilton et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
p16INK4a Translation Suppressed by miR-24
Ashish Lal et al.
PLOS ONE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Distinct methylation profiles of glioma subtypes
K Uhlmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas
S Loeper et al.
CYTOGENETICS AND CELL GENETICS (2001)